Master Mar 24, 2021 Early training delays symptom onset in mouse model… Researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital reported that, in a… Read Article Mar 18, 2021 DNA elements IDed that affect MECP2 expression Researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital (NRI) have… Read Article Mar 15, 2021 Study finds antisense oligonucleotides to treat MECP2… A preclinical study published from the laboratory of Dr. Huda Zoghbi, professor at Baylor College of Medicine and director of the Jan and Dan Duncan… Read Article Mar 11, 2021 Grant to test genetics to help diabetes type… Baylor College of Medicine will serve as the lead center among a multicenter, international project aiming to use genetics to diagnose diabetes in… Read Article Mar 10, 2021 Microbes may hold the key for treating neurological… When we think about the causes of neurological disorders and how to treat them, we think about targeting the brain. But is this the best or only way… Read Article Mar 4, 2021 Proteomics analysis IDs potential drug targets… Researchers at Baylor College of Medicine show that analysis of the proteomics, or all the protein data, from aggressive human cancers is a useful… Read Article Mar 1, 2021 Support for SETBP1 Research at Baylor and TCH On December 1, 2020, people from all over the world came together to virtually support and donate to beloved non-profit organizations. The SETBP1… Read Article Mar 1, 2021 Weathering the storm: focus on your mental health Disaster after disaster often leads to distress. Following the winter storm in Texas, many re-experienced the traumatic effects of Hurricane Harvey,… Read Article Feb 25, 2021 Trial results show potential benefits of tocilizumab… Tocilizumab (TCZ) is one of multiple drugs that have been studied in clinical trials around the world as a potential treatment for COVID-19. A team… Read Article Feb 23, 2021 Targeting MAPK4: potential therapy for prostate cancer The battle against late-stage prostate cancer might have found a potential new strategy to combat this deadly disease. Research led by Baylor College… Read Article Feb 19, 2021 SRC-3: novel regulator of T regulatory cells A study led by researchers at Baylor College of Medicine reveals a novel role of the steroid receptor coactivator 3 (SRC-3/NCOA3), a protein crucial… Read Article Feb 9, 2021 Getting ahead of the infection - phages anticipate… Researchers at Baylor College of Medicine and other institutions have identified a novel strategy that can eliminate bacteria in a specific location… Read Article Feb 9, 2021 NASA grants renewal and funding for deep space health… NASA has renewed the Translational Research Institute for Space Health (TRISH) until 2028. TRISH works closely with NASA’s Human Research Program in… Read Article Feb 4, 2021 Duration of antibody response varies in adults with RSV Researchers at Baylor College of Medicine found that while most individuals responded to respiratory syncytial virus (RSV) natural reinfection with a… Read Article Feb 3, 2021 Examining resistance to breast cancer treatments The combination of CDK4/6 inhibitors with endocrine therapy is the standard of care for patients with estrogen receptor-positive (ER+) and HER2-… Read Article Jan 22, 2021 3-D printed biomesh minimizes hernia repair complications Although hernia mesh implants are mechanically strong and support abdominal tissue it is a common problem that the implant can drive inflammation… Read Article Pagination Previous page Page 8 Page 9 Page 10 Page 11 Current page 12 Page 13 Page 14 Page 15 Page 16 Next page